Applying complexed prostate-specific antigen to clinical practice

Urology. 2004 May;63(5):815-8. doi: 10.1016/j.urology.2004.01.033.

Authors

J Kellogg Parsons¹, Alan W Partin

Affiliation

¹ James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA.

PMID: 15134952
DOI: 10.1016/j.urology.2004.01.033

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Humans
Male
Mass Screening / methods
Neoplasm Recurrence, Local / blood
Prostate-Specific Antigen / blood*
Prostatic Neoplasms / blood*
Prostatic Neoplasms / pathology

Substances

Prostate-Specific Antigen